pharmaceutical investing AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
pharmaceutical investing AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
pharmaceutical investing AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
pharmaceutical investing U.S. FDA Approves DECNUPAZTM for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options
pharmaceutical investing AbbVie Announces Positive CHMP Opinion for MAVIRET® for the Treatment of Acute Hepatitis C Infection
pharmaceutical investing AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
pharmaceutical investing Allergan Aesthetics Receives Positive CHMP Opinion for Boey® for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults
pharmaceutical investing AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases at 2026 Digestive Disease Week®
pharmaceutical investing SKYRIZI® Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis
pharmaceutical investing AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
pharmaceutical investing AbbVie Submits Application to FDA for Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
pharmaceutical investing RINVOQ® Demonstrated Superiority Versus HUMIRA® for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF inhibitor
pharmaceutical investing EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie
Steadright Removes Titanbeach One Technical Report And Retains Qualified Geologist For New Technical Report
The Metal You've Never Heard Of Is Becoming a National-Security Priority -- and America Barely Mines It
